Why the study?
Increasing numbers of patients with Chagas cardiomyopathy are admitted to US hospitals due to immigration and globalization, necessitating clinician education on how it differs from common ischemic and nonischemic forms.
Key points are not available for this paper at this time.
Design
Overview article
Answers are grounded in this paper and cite their sources.
Supports nurse education on Chagas cardiomyopathy amid rising US cases; leaves open implementation strategies and outcome impacts.
Chagas disease is a prominent neglected tropical disease endemic to many countries in Latin America. Cardiomyopathy is the most serious manifestation due to the severity and complications of heart failure. As a result of expanded immigration and globalization, there is an increased number of patients with Chagas cardiomyopathy who are being admitted to hospitals in the United States. It is imperative as a critical care nurse to be educated on the nature of Chagas cardiomyopathy as it differs from the more commonly seen ischemic and nonischemic forms. This article provides an overview of the clinical course, management, and treatment options of Chagas cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Jimenez et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: